Tratamiento hipercalcêmico em nefropata pós paratireoidectomia: relato de caso

Sousa, Bruno Soares de; Cirilo, Marry Aneyts De Santana; Melo, Halanna Celina Magalhães; Morais, Caroline Neves de; Melo, Janatar Stella Vasconcelos de.
Nutr. clín. diet. hosp ; 36(3): 19-23, 2016. tab, graf
Artículo en Portugués | IBECS (España) | ID: ibc-180007

Documentos relacionados

  1. The dietary management of calcium and phosphate in children with CKD stages 2-5 and on dialysis-clinical practice recommendation from the Pediatric Renal Nutrition Taskforce.
  2. The dietary management of potassium in children with CKD stages 2-5 and on dialysis-clinical practice recommendations from the Pediatric Renal Nutrition Taskforce.
  3. Regression of vascular calcification in a parathyroidectomized patient on dialysis with untreated hypocalcemia over 12-year follow-up
.
  4. State-of-the-Art Management of Hyperphosphatemia in Patients With CKD: An NKF-KDOQI Controversies Perspective.
  5. Physical activity and nutrition in chronic kidney disease.
  6. Authors' Reply: Calcium-Based Phosphate Binders and Plasma Oxalate Concentration in Dialysis Patients.
  7. [The serum level of the morphogenetic protein fibroblast growth factor 23 (FGF-23) as a marker for the efficiency of hyperphosphatemia therapy with phosphate-binding agents in chronic kidney disease].
  8. A Randomized Trial of Tenapanor and Phosphate Binders as a Dual-Mechanism Treatment for Hyperphosphatemia in Patients on Maintenance Dialysis (AMPLIFY).
  9. Pro: The rationale for dietary therapy for patients with advanced chronic kidney disease.
  10. Effects of lanthanum carbonate and calcium carbonate on cardiovascular calcification in hemodialysis patients: A systematic review and meta-analysis.